{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:34:32Z","timestamp":1787002472371,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"vor","delay-in-days":170,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/mt.2016.55","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T07:21:16Z","timestamp":1457508076000},"page":"1090-1099","source":"Crossref","is-referenced-by-count":40,"title":["Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes"],"prefix":"10.1016","volume":"24","author":[{"given":"Sheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soghra","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taihe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J","family":"Janke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.55_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2016.55_bib2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.55_bib3","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott\u2013Aldrich syndrome\u2014long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2016.55_bib4","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2005-08-024976","article-title":"Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity","volume":"108","author":"Modlich","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib5","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors","volume":"17","author":"Modlich","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.55_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration","volume":"24","author":"Montini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2016.55_bib7","doi-asserted-by":"crossref","first-page":"e62333","DOI":"10.1371\/journal.pone.0062333","article-title":"Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.55_bib8","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1182\/blood-2007-04-085506","article-title":"An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation","volume":"111","author":"Ryu","year":"2008","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2009-10-250209","article-title":"A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/mt.2014.95","article-title":"Charting a clear path: the ASGCT Standardized Pathways Conference","volume":"22","author":"Kiem","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.55_bib11","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1182\/blood-2010-09-309831","article-title":"Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies","volume":"117","author":"Treanor","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1182378","article-title":"The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal","volume":"327","author":"McCormack","year":"2010","journal-title":"Science"},{"key":"10.1038\/mt.2016.55_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature06840","article-title":"The earliest thymic progenitors for T cells possess myeloid lineage potential","volume":"452","author":"Bell","year":"2008","journal-title":"Nature"},{"key":"10.1038\/mt.2016.55_bib14","first-page":"853","article-title":"The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice","volume":"11","author":"Larson","year":"1995","journal-title":"Oncogene"},{"key":"10.1038\/mt.2016.55_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1084\/jem.20122727","article-title":"Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential","volume":"211","author":"Treanor","year":"2014","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2016.55_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1074-7613(02)00474-0","article-title":"Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro","volume":"17","author":"Schmitt","year":"2002","journal-title":"Immunity"},{"key":"10.1038\/mt.2016.55_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/hum.2007.021","article-title":"Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects","volume":"18","author":"Aker","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.55_bib18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2016.55_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.55_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/mthe.2002.0549","article-title":"Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood","volume":"5","author":"Hanawa","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.55_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.69.2.748-755.1995","article-title":"Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells","volume":"69","author":"Challita","year":"1995","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.55_bib22","doi-asserted-by":"crossref","first-page":"e6995","DOI":"10.1371\/journal.pone.0006995","article-title":"The 3\u2032 region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity","volume":"4","author":"Arumugam","year":"2009","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.55_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/humc.2012.244","article-title":"Comparison of insulators and promoters for expression of the Wiskott\u2013Aldrich syndrome protein using lentiviral vectors","volume":"24","author":"Koldej","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1038\/mt.2016.55_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/hgtb.2014.122","article-title":"Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems","volume":"26","author":"Zhou","year":"2015","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mt.2016.55_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1038\/mt.2016.55_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1038\/mt.2016.55_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Zuurbier","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/mt.2016.55_bib28","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1182\/blood-2008-07-167577","article-title":"Mef2C is a lineage-restricted target of Scl\/Tal1 and regulates megakaryopoiesis and B-cell homeostasis","volume":"113","author":"Gekas","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib29","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/JVI.00011-14","article-title":"Enhancers are major targets for murine leukemia virus vector integration","volume":"88","author":"De Ravin","year":"2014","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.55_bib30","doi-asserted-by":"crossref","first-page":"e85883","DOI":"10.1371\/journal.pone.0085883","article-title":"LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.55_bib31","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1002\/stem.2049","article-title":"Hhex is required at multiple stages of adult hematopoietic stem and progenitor cell differentiation","volume":"33","author":"Goodings","year":"2015","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2016.55_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1038\/mt.2016.55_bib33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.mt.6300103","article-title":"Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector","volume":"15","author":"Evans-Galea","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.55_bib34","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1158\/1078-0432.CCR-10-0440","article-title":"The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia","volume":"16","author":"Curtis","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2016.55_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.55_bib36","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra032207","article-title":"Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency","volume":"350","author":"McCormack","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2016.55_bib37","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2005-03-1113","article-title":"Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells","volume":"106","author":"Du","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib38","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2004-12-4840","article-title":"Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis","volume":"106","author":"Du","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib39","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/leu.2008.118","article-title":"Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16","volume":"22","author":"Modlich","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/mt.2016.55_bib40","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2013-10-534735","article-title":"Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo","volume":"124","author":"Yu","year":"2014","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1038\/mt.2016.55_bib42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.55_bib43","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/mt.2009.183","article-title":"Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region","volume":"17","author":"Arumugam","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.55_bib44","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1182\/blood-2011-03-340711","article-title":"Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott\u2013Aldrich syndrome","volume":"119","author":"Astrakhan","year":"2012","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nbt.3062","article-title":"Genomic discovery of potent chromatin insulators for human gene therapy","volume":"33","author":"Liu","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2016.55_bib46","doi-asserted-by":"crossref","first-page":"e76528","DOI":"10.1371\/journal.pone.0076528","article-title":"Identification and characterization of enhancer-blocking insulators to reduce retroviral vector genotoxicity","volume":"8","author":"Groth","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.55_bib47","first-page":"2217","article-title":"Tumor spectrum in ARF-deficient mice","volume":"59","author":"Kamijo","year":"1999","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2016.55_bib48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V93.2.488","article-title":"Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis","volume":"93","author":"Persons","year":"1999","journal-title":"Blood"},{"key":"10.1038\/mt.2016.55_bib49","doi-asserted-by":"crossref","first-page":"14063","DOI":"10.1038\/mtm.2014.63","article-title":"Generation of a lentiviral vector producer cell clone for human Wiskott\u2013Aldrich syndrome gene therapy","volume":"2","author":"Wielgosz","year":"2015","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T18:28:29Z","timestamp":1600280909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616303768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1525001616303768"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.55","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}